Randomised, double-blind, crossover study of single dose armodafinil in patients with shift work sleep disorder.
Phase of Trial: Phase IV
Latest Information Update: 06 May 2014
Price : $35 *
At a glance
- Drugs Armodafinil (Primary)
- Indications Circadian rhythm sleep disorders
- Focus Therapeutic Use
- Sponsors Teva Pharmaceutical Industries
- 06 May 2014 New trial record
- 08 Apr 2014 Results published in the Journal of Clinical Psychopharmacology.